(1-BENZYLCARBAMOYL-2-METHOXY-ETHYL)-CARBAMIC ACID TERT-BUTYL ESTER, 99.0%, 250mg

7-Bromoquinoline-2-carboxylic acid, 95.0%, 25g

3-Nitropyridine-2-thiol, 95.0%, 5g

2-THIOPHENECARBOXAMIDE, N-[(1S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL]-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-, HCL (1:1), 95%, 50mg

(7S,9S)-9-Acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione, 97.0%, 250mg

Filtration unit Rapid-Flow with PES membrane Pore size 0.45 μm, 150 ml, 150 ml, 50 mm, 12 Piece(s)

4-Chloro-3-iodo-1H-pyrrolo[3,2-c]pyridine, 95+%, 10g

Ethyl (2-chloro-5-thenoyl)acetate, 95.0%, 10g

1-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95.0%, 500mg

2-((TERT-BUTOXYCARBONYL)(METHYL)AMINO)-2-(4-METHOXYPHENYL)ACETIC ACID, 95.0%, 1g

2-(3-Bromo-4-fluorophenyl)piperazine, 97.0%, 1g

4-Fluoro-benzimidic acid ethyl ester; hydrochloride, 95.0%, 1g

2,2-DIMETHYL-2H-BENZO[B][1,4]THIAZIN-3(4H)-ONE, 97.0%, 1g